Hartmut Koeppen
Genentech · 106 works · 8,781 citations · h-index 36
Top works
- Safety and antitumor activity of recombinant soluble Apo2 ligand
- Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate
- A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.
- A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes
- Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity.
- POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANTATION
- Antigenic Cancer Cells Grow Progressively in Immune Hosts without Evidence for T Cell Exhaustion or Systemic Anergy
- Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells.
- Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer.
- Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
- Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
- Isotype-Dependent Inhibition of Tumor Growth In Vivo by Monoclonal Antibodies to Death Receptor 4
- Biomarkers and associations with the clinical activity of PD-L1 blockade in a MPDL3280A study.
- Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth.
- Ascl2 and 11p15.5 amplification in colorectal cancer
- Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.
- An interleukin 12-related cytokine is up-regulated in ulcerative colitis but not in Crohn's disease
- HER2-Targeted Therapy Reduces Incidence and Progression of Midlife Mammary Tumors in Female Murine Mammary Tumor Virus huHER2-Transgenic Mice
- Phosphoinositide 3-Kinase (PI3K) Pathway Alterations Are Associated with Histologic Subtypes and Are Predictive of Sensitivity to PI3K Inhibitors in Lung Cancer Preclinical Models
- Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen.